FDA Label for Bisoprolol Fumarate And Hydrochlorothiazide
View Indications, Usage & Precautions
Bisoprolol Fumarate And Hydrochlorothiazide Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
NDC 70771-1760-3
Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 2.5 mg/6.25 mg
30 Tablets Unit-of-Use
Rx only
NDC 70771-1761-3
Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 5 mg/6.25 mg
30 Tablets Unit-of-Use
Rx only
NDC 70771-1762-3
Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 10 mg/6.25 mg
30 Tablets Unit-of-Use
Rx only
* Please review the disclaimer below.